[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE128716T1 - Hiv-peptide und methoden für den nachweis von hiv. - Google Patents

Hiv-peptide und methoden für den nachweis von hiv.

Info

Publication number
ATE128716T1
ATE128716T1 AT88118299T AT88118299T ATE128716T1 AT E128716 T1 ATE128716 T1 AT E128716T1 AT 88118299 T AT88118299 T AT 88118299T AT 88118299 T AT88118299 T AT 88118299T AT E128716 T1 ATE128716 T1 AT E128716T1
Authority
AT
Austria
Prior art keywords
hiv
peptides
methods
detecting
disclosed
Prior art date
Application number
AT88118299T
Other languages
English (en)
Inventor
Virender K Sarin
Kevin M Knigge
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE128716T1 publication Critical patent/ATE128716T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT88118299T 1987-11-24 1988-11-03 Hiv-peptide und methoden für den nachweis von hiv. ATE128716T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12480187A 1987-11-24 1987-11-24

Publications (1)

Publication Number Publication Date
ATE128716T1 true ATE128716T1 (de) 1995-10-15

Family

ID=22416845

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88118299T ATE128716T1 (de) 1987-11-24 1988-11-03 Hiv-peptide und methoden für den nachweis von hiv.

Country Status (8)

Country Link
EP (1) EP0317804B1 (de)
JP (1) JPH01165598A (de)
KR (1) KR890008565A (de)
AT (1) ATE128716T1 (de)
AU (1) AU621317B2 (de)
CA (1) CA1340157C (de)
DE (1) DE3854550T2 (de)
ES (1) ES2080047T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1219232A (en) * 1983-08-17 1987-03-17 Richard A. Lerner Polypeptide-induced monoclonal receptors to protein ligands
US5939074A (en) * 1986-12-30 1999-08-17 The United States Of America As Represented By The Department Of Health And Human Services Multideterminant peptide antigens
US4865966A (en) * 1987-04-17 1989-09-12 New York University Method for detecting antibodies to human immunodeficiency virus
US5876724A (en) * 1990-03-19 1999-03-02 Institut Pasteur Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
WO1992005196A1 (en) * 1990-09-25 1992-04-02 Hiver Limited Aids therapy and vaccine
JPH07501516A (ja) * 1991-08-29 1995-02-16 アメリカ合衆国 ヒトの被験者におけるｈｉｖに反応するヘルパーｔリンパ球を刺激する多重決定基ペプチド抗原
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
US6846905B2 (en) 1997-08-15 2005-01-25 Abbott Laboratories Antigen constructs useful in the detection and differentiation of antibodies to HIV
US7736909B2 (en) 2003-01-09 2010-06-15 Board Of Regents, The University Of Texas System Methods and compositions comprising capture agents
DE102006012885A1 (de) * 2006-03-18 2007-09-20 Institut Virion/Serion Gmbh Diagnostisches Testsystem zum simultanen, quantitativen Nachweis von HIV1 und HIV2 Antikörpern und/oder HIV Antigenen in humanem Probenmaterial
EP2438444A1 (de) 2009-06-02 2012-04-11 The Board of Regents of The University of Texas System Identifizierung von antikörpern bei patienten mit neurodegenerativen krankheiten erkannter kleiner moleküle
US8759259B2 (en) 2009-10-16 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for producing cyclic peptoid libraries
CA2821995C (en) * 2011-01-06 2019-02-12 Bionor Immuno As Monomeric and multimeric peptides immunogenic against hiv

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0387914B1 (de) * 1984-10-18 1993-08-04 Institut Pasteur Hüllenantigene vom menschlichen Immunodefizienz-Virus und deren Verwendungen
JPS61188356A (ja) * 1985-02-18 1986-08-22 Ricoh Co Ltd 並列搬送型複写機
EP0212532A1 (de) * 1985-08-12 1987-03-04 Syntex (U.S.A.) Inc. Verfahren zur Herstellung von Fusionsproteinen
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
AU1711888A (en) * 1987-04-24 1988-12-02 Biogen, Inc. Immunotherapeutic methods and compositions
GB8714802D0 (en) * 1987-06-24 1987-07-29 Proteus Biotech Ltd Synthetic polypeptides
DE3877294T2 (de) * 1987-09-04 1993-05-06 Int Murex Tech Corp Festphasenimmunoassay fuer einen antikoerper und hierbei verwendete biologische produkte.

Also Published As

Publication number Publication date
DE3854550D1 (de) 1995-11-09
ES2080047T3 (es) 1996-02-01
KR890008565A (ko) 1989-07-12
EP0317804B1 (de) 1995-10-04
EP0317804A3 (en) 1990-09-12
AU621317B2 (en) 1992-03-12
DE3854550T2 (de) 1996-04-25
AU2567888A (en) 1989-05-25
CA1340157C (en) 1998-12-01
JPH01165598A (ja) 1989-06-29
EP0317804A2 (de) 1989-05-31

Similar Documents

Publication Publication Date Title
ATE364621T1 (de) Hiv-peptide
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
ATE99330T1 (de) Rekombinantes viren-ueberzugsprotein assoziiert mit ''acquired immune deficiency syndrome'' (aids) und verfahren zur testung von aids.
ATE90384T1 (de) Rekombinante virusproteine begleitet von lymphadenopathischem syndrom und/oder ''acquired immune deficiency syndrome'' (aids).
EP0245362A4 (de) Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
NO169844C (no) Htlv-iii (env)-peptider
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
ES2054769T3 (es) Polipeptidos hiv-2 recombinantes.
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
ATE147759T1 (de) Verfahren und materialien zum nachweis und therapie von hiv
ATE119166T1 (de) An hiv relatierte peptide.
DE69012989D1 (de) Peptiden von retinblastoma gen produkten und antikoerper dagegen.
ATE130050T1 (de) Verfahren zum schnellen und empfindlichen nachweis von hiv-1-antikörpern.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee